Patent Description:
Nerve injuries may cause partial or total loss of motor and sensory functions and lead to a high disability rate, with clinical manifestations of flaccid tendons and vessels, myasthenia, skin numbness, body weakness, limb numbness and even paralysis, belonging to "flaccidity syndrome", "arthromyodynia" and the like according to the dialectics of traditional Chinese medicine. Due to the nerve injuries caused by accidents related to modern traffic, work accidents, earthquake disasters, wars, tumor operations, etc., the incidence of nerve injuries is increasing year by year, which severely affects the living quality of the patients and brings heavy financial and social burdens to the society and their families. For more than a century, how to promote the restoration and regeneration of the damaged nerves has always been a major challenge and a hot topic in the fields of pharmacy, neuroscience and medicine.

At present, few drugs are clinically available for nerve injuries. Treatment of central nerve injuries using a nerve growth factor (NGF) has a certain efficacy. However, since the NGF is extracted from a culture solution of brain glioma cells, clinical trials of NGF have a potential risk of inducing tumors. For peripheral nerve injuries, vitamin B6 is adopted clinically, and mecobalamin (Methycobal) is a vitamin derivative and has a certain efficacy. Clinical practices in decades indicate that a drug treatment mode of "one drug for one target for one disease" has a great limitation, and provides poor clinical efficacy.

Therefore, it is an expectation of the majority of patients, a major demand of the society and a need of innovations in human neuroscience, pharmacy and medicine to research and develop a safe and effective traditional Chinese medicine for promoting neuranagenesis.

How to solve the above-mentioned technical problem is the topic of the present invention. Patent applications <CIT>, <CIT>, and <CIT> give examples of traditional Chinese medicine compositions for treating nerve injury, and using Astragali radix and Angelicae Sinensis as main ingredients. Chinese patent application <CIT> gives an example of a composition for neuropathy including Zaocys, Jujubae, Lyil fructus and Poria. Chinese patent applications <CIT>, <CIT>, and <CIT> also provide examples of different mixtures of raw medicinal ingredients for therapeutic uses.

The present invention is defined in the appended set of claims. An objective of the present invention is to provide a compound preparation for neuranagenesis, in particular for the treatment of nerve injuries, and a preparation method therefor and use thereof to address the above-mentioned problem, where the compound preparation has obvious effects of promoting nerve growth, promoting myelination of the regenerated nerves, promoting reinnervation of the denervated target muscles and providing protection after nerve injuries, thereby providing a scientific basis for the effect of traditional Chinese medicine in promoting neuranagenesis after injuries, and laying a firm foundation for clinical application of the prescription.

In order to achieve the above-mentioned objective of the present invention, the present invention proposes a compound preparation according to claim <NUM>.

Further, the compound preparation comprises an effective dose of the formulation components of the compound preparation and pharmaceutically acceptable excipients.

In order to better achieve the above-mentioned objective of the present invention, the present invention also provides a method for preparing a compound preparation, where when the dosage form of the compound preparation is oral liquid, the preparation method comprises the following steps:.

In order to better achieve the above-mentioned objective of the present invention, the present invention also provides a method for preparing a compound preparation with a dosage form of granules, where the preparation method comprises the following steps:.

Further, use of the compound preparation for neuranagenesis in drugs for treating nerve damage diseases.

Further, the monarch drugs of the compound preparation: raw Astragali radix, Rehmaimiae radix praeparata, Actyranthes bidentata, Jujubae fructus, Lycii fructus and parched Ziziphi spinosae semen; ministerial drugs: Angelicae smensis radix and Carthami flos; adjuvants: Poria and parched Atractylodis macrocephalae rhizoma; and conductant drug: Zaocys.

Further, the compound preparation has the functions of tonifying qi and replenishing blood, tonifying five internal organs, promoting nerve growth, promoting myelination, and clearing and activating the channels and collaterals, and is suitable for the conditions after nerve injuries of deficiency of qi and blood, disharmony in channels and collaterals, myasthenia, skin numbness and acral weakness.

In particular, the invention also concerns a compound preparation according to claim <NUM>, and its use for treating nerve injury, notably sciatic nerve injury.

Compared with the prior art, the present invention has the following beneficial effects:.

The compound preparation provided by the present invention has obvious effects of promoting nerve growth, promoting myelination of the regenerated nerves, promoting myelination of the denervated target muscles and providing protection after nerve injuries, thereby providing a scientific basis for traditional Chinese medicine that promotes neuranagenesis after injuries, and laying a firm foundation for clinical application of the prescription.

The present invention adopts the following technical solution: a compound preparation, where the compound preparation includes the raw medicinal materials in parts by weight: <NUM>-<NUM> parts of raw Astragali radix, <NUM>-<NUM> parts of Rehmaimiae radix praeparata, <NUM>-<NUM> parts of Actyranthes bidentata, <NUM>-<NUM> parts of Jujubae fructus, <NUM>-<NUM> parts of Lycii fructus, <NUM>-<NUM> parts of parched Ziziphi spinosae semen, <NUM>-<NUM> parts of Angelicae smensis radix, <NUM>-<NUM> parts of Carthami flos, <NUM>-<NUM> parts of Poria, <NUM>-<NUM> parts of parched Atractylodis macrocephalae rhizoma and <NUM>-<NUM> parts of Zaocys.

Specifically, the compound preparation includes the raw medicinal materials consisting in parts by weight of: <NUM> parts of raw Astragali radix, <NUM> parts of Rehmaimiae radix praeparata, <NUM> parts of Actyranthes bidentata, <NUM> parts of Jujubae fructus, <NUM> parts of Lycii fructus, <NUM> parts of parched Ziziphi spinosae semen, <NUM> parts of Angelicae smensis radix, <NUM> parts of Carthami flos, <NUM> parts of Poria, <NUM> parts of parched Atractylodis macrocephalae rhizoma and <NUM> parts of Zaocys.

Specifically, the compound preparation also includes an effective dose of the formulation components of the compound preparation and pharmaceutically acceptable excipients.

In order to better achieve the objective of the present invention, the present invention also provides a method for preparing a compound preparation, where when the dosage form of the compound preparation is oral liquid, the preparation method includes the following steps:.

In order to better achieve the objective of the present invention, the present invention also provides a method for preparing a compound preparation with a dosage form of granules, where the preparation method includes the following steps:.

Specifically, use of the compound preparation in drugs for treating nerve damage diseases.

Specifically, the monarch drugs of the compound preparation: raw Astragali radix, Rehmaimiae radix praeparata, Actyranthes bidentata, Jujubae fructus, Lycii fructus and parched Ziziphi spinosae semen; ministerial drugs: Angelicae smensis radix and Carthami flos; adjuvants: Poria and parched Atractylodis macrocephalae rhizoma; and conductant drug: Zaocys.

Specifically, the compound preparation has the functions of tonifying qi and replenishing blood, tonifying five internal organs, promoting nerve growth, promoting myelination, and clearing and activating the channels and collaterals, and is suitable for the conditions after nerve injuries of deficiency of qi and blood, disharmony in channels and collaterals, myasthenia, skin numbness and acral weakness.

A process of preparing the oral liquid of the present invention was: <NUM> parts of raw Astragali radix, <NUM> parts of Rehmaimiae radix praeparata, <NUM> parts of Actyranthes bidentata, <NUM> parts of Jujubae fructus, <NUM> parts of Lycii fructus, <NUM> parts of parched Ziziphi spinosae semen, <NUM> parts of Angelicae smensis radix, <NUM> parts of Carthami flos, <NUM> parts of Poria, <NUM> parts of parched Atractylodis macrocephalae rhizoma and <NUM> parts of Zaocys were taken.

A preparation method therefor included the following steps:.

Materials and methods: <NUM> SD rats were randomly divided into <NUM> groups, where low-dose, medium-dose and high-dose groups of the oral liquid of the compound preparation were administered with crude drugs at a dose of <NUM>/kg, <NUM>/kg and <NUM>/kg respectively, a Mecobalamin group was administered at a dose of <NUM>µg/kg, and a control group was given with double distilled water at an equivalent volume.

A rat sciatic nerve injury model was established by referring to the paper and method published by Smith GM et al. , and SFI (sciatic functional index) determination, histological examination and statistical treatment of data were performed.

Results: the traditional Chinese medicine group and the Mecobalamin group were obviously superior to the blank control group in terms of SFI, and statistical analysis indicated P<<NUM> and a significant difference; and through histological examination, in the traditional Chinese medicine group using the compound preparation of the present invention, densely regenerated nerve fibers and thick myelin sheath could be seen, which was obviously better than in the blank control group, and statistical analysis indicated P<<NUM> and a significant difference.

The results indicate that: the compound preparation of the present invention can promote regeneration, myelination and functional recovery of the injured sciatic nerves in rats.

Example <NUM>: Study on a protective effect of the compound preparation for ischemic brain injury in rats.

Materials and methods: <NUM> SD rats were randomly divided into <NUM> groups: low-dose, medium-dose and high-dose groups of the oral liquid of the compound preparation, a Huatuo Zaizao pill group (positive control) and an ischemic group (negative control). The low-dose, medium-dose and high-dose groups of traditional Chinese medicine were administered at a dose of <NUM>/kg, <NUM>/kg and <NUM>/kg respectively; the Huatuo Zaizao pill group was administered at a dose of <NUM>/kg; and the ischemic control group was given with double distilled water at an equivalent volume. Neurological function scoring criteria (Methodology of Modern Pharmacological Testing (Second Volume)) (notes: scoring criteria: with a full score of <NUM>, a higher score indicates a more severe animal behavior disorder); and determination of SOD activity and MDA content in serum, determination of infarction volume, observation of pathological tissues, observation of ultrastructures and statistical treatment of data were performed.

Results: (<NUM>) in the high-dose group of traditional Chinese medicine and the Huatuo Zaizao pill group, the scores of neurological functions in rats at <NUM>, <NUM>, and <NUM> were significantly decreased (P<<NUM> and <NUM>).

Claim 1:
A compound preparation, wherein the compound preparation comprises raw medicinal materials consisting of: <NUM> parts by weight of raw Astragali radix, <NUM> parts by weight of Rehmaimiae radix praeparata, <NUM> parts by weight of Actyranthes bidentata, <NUM> parts by weight of Jujubae fructus, <NUM> parts by weight of Lycii fructus, <NUM> parts by weight of parched Ziziphi spinosae semen, <NUM> parts by weight of Angelicae smensis radix, <NUM> parts by weight of Carthami flos, <NUM> parts by weight of Poria, <NUM> parts by weight of parched Atractylodis macrocephalae rhizoma and <NUM> parts by weight of Zaocys, and wherein a dosage form of the compound preparation is oral or granules, and is prepared by rinsing the medicinal materials with water to remove impurities;
(<NUM>) soaking the raw materials in deionized water at <NUM> for <NUM>;
(<NUM>) performing water extraction, and decocting at <NUM> for <NUM>;
(<NUM>) taking the decoction and allowing same to stand at <NUM> for <NUM> under sterile conditions, performing filtration and concentration, and adding benzoic acid or sodium benzoate; and
(<NUM>) performing filling and sterilization to obtain an oral liquid, or
(<NUM>) performing drying, granulation, filling and sterilization to obtain granules.